戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ernatively spliced 57kT forms of MCPyV large T antigen.
2  genome has undergone mutations in the large T antigen.
3 D patients were transformed using SV40 large T antigen.
4  of the role of simian virus 40 (SV40) small t antigen.
5 sion in mice that express the Polyoma middle T antigen.
6  MCC tumors that fail to express MCPyV large T antigen.
7 xpresses small T antigen and truncated large T antigen.
8 nd in only 1 of 56 tumors positive for large T antigen.
9 arrying the gene encoding the polyoma middle T antigen.
10  methylation, and John Cunningham (JC) virus T antigen.
11 an essential step in unwinding origin DNA by T antigen.
12 cificity for conserved epitopes of JCV large T antigen.
13 mune response to peptides encoding BKV large T antigen.
14  immortalized with telomerase and SV40 large T antigen.
15  Golgi, resulting in the formation of sialyl-T antigen.
16 n small T antigen (sTAg) and truncated large T antigen.
17 origin-binding domain of virus-encoded large T antigen.
18 ncy was the principal carcinogenic effect of T-antigen.
19 ost tumors express the MCPyV large and small T antigens.
20 mian virus 40 (SV40) large (T) and small (t) T antigens.
21 y test both tumor-derived and wild type (WT) T antigens.
22 r MUC1 carrying one or more Tn, T, or sialyl-T antigens.
23 y of MCCs, may drive tumorigenesis via viral T antigens.
24  the use of WbiP for the facile synthesis of T-antigens.
25 spect to the early gene products, the tumor (T) antigens.
26 imeric reporters containing the entire BPCV1 T antigen 3' UTR undergo negative regulation when coexpr
27 or virus promoter-driven polyomavirus middle T antigen, a tumor in which beta1-integrin function is i
28 eased in proportion to the reduction in p68N-T antigen affinity, confirming that p68-T antigen intera
29                                         SV40 T antigen also induces H3K18 hypoacetylation.
30             Other polyomavirus-encoded large T antigens also increase the levels of CBP/p300 and sust
31 cript between a previously undescribed virus T antigen and a human receptor tyrosine phosphatase.
32  HPV E7 proteins, as well as simian virus 40 T antigen and adenovirus E1A, can associate with and ina
33  subunits as well as for the localization of T antigen and damage-signaling proteins to viral replica
34 nd viral oncogenes, including the SV40 large T antigen and human papilloma virus 16 E6-antigen.
35 mmortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OS
36 ing partner of the mouse polyoma virus large T antigen and later shown to possess tumor suppressor-li
37 l body numbers, and expression of SV40 large T antigen and oncogenic Ras.
38 AX, and Mre11-Rad50-Nbs1 (MRN) assemble with T antigen and other viral DNA replication proteins in la
39  of a kinase activity associated with middle T antigen and our serendipitous discovery that this acti
40    On the other hand, SVST complements large T antigen and Ras for the transformation of human mammar
41          It is predicted to encode the large T antigen and small T antigen early proteins and the VP1
42 es previously immortalized by the SV40 large T antigen and telomerase.
43  The fraction of cells expressing SV40 large T antigen and the levels of T antigen mRNA were reduced
44 helicases, such as the simian virus 40 large T antigen and the papillomavirus E1 protein, are active
45 hromosomes of MCC tumors and expresses small T antigen and truncated large T antigen.
46 rocytes, which instead expressed early viral T antigens and exhibited apoptotic death.
47 les, specifically the simian virus 40 (SV40) T antigens and oncogenic Ras(12V), affect fatty acid met
48  only recognizes Gal beta1,3GalNAc alpha-OR (T-antigen and derivatives) as the acceptor to generate t
49 cin origin, with terminal fucose, the sialyl T-antigen, and N-linked oligosaccharides identified as p
50 me or all of the functions of the SV40 small T antigen, another well-characterized oncoprotein, in tw
51 cture of the hexameric helicase of JCV large T antigen (apo) and its use to drive the structure-based
52 tly focused on a few epitopes within variant TS antigens appear to neither contribute to, nor detract
53 ons of full-length and truncated MCPyV large T antigen are unknown.
54 criptase (hTERT) plus SV40 large T and small T antigens are transformed by either oncogenic Ras (H-Ra
55            These results indicate that MCPyV T antigens are tumorigenic in vivo, consistent with thei
56         We further show that the BKPyV large T antigen, as well as large T antigens from related poly
57 ecule and ensemble assays to show that large T antigen assembled on the SV40 origin unwinds DNA effic
58              This enzyme binds to SV40 large T antigen at two places, close to the N-terminal end and
59 s long-terminal region-driven polyoma middle T antigen breast cancer model.
60                        By binding YAP, small t antigen brings it together with protein phosphatase 2A
61                                    JCV large T antigen, but not VP1 capsid protein, was expressed in
62 ere positive for early SV40 transcript large T antigen, but only 4 of the 14 cases exhibited late vir
63 uch as retinoblastoma (RB1) by mutated viral T antigens, but the molecular pathogenesis of MCPyV-nega
64 loping antibodies capable of detecting large T antigen by immunohistochemistry.
65   In contrast, expression of the MCPyV large T antigen C-terminal 100 residues could inhibit the grow
66 how that the oncogenes simian virus 40 large T antigen, c-Myc, and cyclin E induce spatial reorganiza
67    However, we have observed that SV40 large T antigen can induce cell proliferation and transformati
68                                The two small T antigens can target different proteins for dephosphory
69 ated a novel mouse hepatocellular SV40 large T-antigen carcinoma cell line, MHT that maintains the ab
70      The analysis of the mechanisms by which T antigen carries out its many functions has proved to b
71 erse transcriptase (hTERT) and/or SV40 large T antigen cDNA vectors, and antibiotic-resistant cells w
72 d anthracyclines were studied in CEA424/SV40 T-antigen (CEA/Tag) transgenic mice, which develop gastr
73 tion of p53 and Rb proteins using SV40 large T antigen completely rescued necrotic cell death.
74 he hexameric replicative helicase SV40 large T antigen, constituting a simple primosome that is activ
75                            On its own, small t antigen controls cell survival and differentiation.
76 ecovery of cellular immune response to large T antigen corresponds with resolution of active BKV infe
77            Our results suggest that the SV40 T antigen could be a valuable tool to dissect cellular a
78                                  MCPyV large T antigen could bind to Rb but was unable to bind to p53
79 arious models are proposed to illustrate how T antigen could separate the central origin.
80  progeny than the wild type, suggesting that T antigen-CUL7-directed proteolysis facilitates virus pr
81 standards sequenced in this study with large T antigen deletions were cultured in cell lines immortal
82                      1) Despite their common T-antigen-derived origins, MIN6 and BTC3 cells display m
83                        Mice expressing MCPyV T antigens developed hyperplasia, hyperkeratosis, and ac
84                       Enzymatic synthesis of T-antigen disaccharides have relied on the use of beta-1
85 ogenesis using an orthotopic, polyoma middle-T antigen-driven model in Foxp3(DTR) knockin mice.
86  form core 1 Galbeta1-3GalNAcalpha1-Ser/Thr (T antigen) during mucin type O-glycan biosynthesis.
87 cted to encode the large T antigen and small T antigen early proteins and the VP1, VP2, and VP3 struc
88 untranslated region (UTR) of the BPCV1 large T antigen early transcript and identified a functional m
89                     The large tumor antigen (T antigen) encoded by simian virus 40 is an amazing mole
90  in combination with wild-type or SV40 large T antigen expressing epithelia resulted in prostates tha
91          Verhaegen et al. report MCPyV small T-antigen-expressing transgenic mice that now provide in
92 3 in the two MCC specimens that lacked large T antigen expression and in only 1 of 56 tumors positive
93 nvestigated any potential link between MCPyV T antigen expression and the highly metastatic nature of
94 rnative mechanisms of negative regulation of T antigen expression between the BPCVs and the polyomavi
95                                        Small t antigen expression blocked both stimulus-induced and c
96 agic acid and spiperone also inhibited large T antigen expression by BK virus and JC virus, two impor
97             These miRNAs negatively regulate T antigen expression by directing small interfering RNA
98 vel monoclonal antibody detected MCPyV large T antigen expression in 56 of 58 (97%) unique MCC tumors
99                                      Ectopic T antigen expression results in the immortalization and
100                          As a consequence of T antigen expression, B cells develop normally but, upon
101 rcentage of BKV infected cells and the large T-antigen expression were significantly decreased in HRP
102  BKV by immunofluorescent analysis and large T-antigen expression which suggested BKV infection by We
103 ols, which was not due to the suppression of T-antigen expression.
104 sX abundance, (b) the fibronectin, collagen, T-antigen (FCT) region of the genome, which contains the
105 he deletion of the C terminus of MCPyV large T antigen found in MCC serves not only to disrupt viral
106  the BKPyV large T antigen, as well as large T antigens from related polyomaviruses, is alone capable
107     These residues are well conserved in the T antigens from the polyomaviruses, indicating that the
108                                              T-Antigen (Gal-beta1,3-GalNAc-alpha-O-Ser/Thr) is an imp
109 major capsid protein gene VP1, and the large T antigen gene.
110  acid reading frame of opposing-strand large T antigen gene.
111 utations were detected in both VP1 and large T antigen genes.
112                     These data indicate that T antigen has a mechanism to specifically unwind the cen
113 68 (p68N) that physically interacts with the T antigen helicase domain.
114 cture of p68N and map its interface with the T antigen helicase domain.
115 due pairs, R498/D499 and R540/D502, in large-T-antigen helicase are critically involved in the transf
116 on structural data for simian virus 40 large-T-antigen helicase revealed a set of nine residues bound
117 ise molecular interactions between the viral T antigen, host replication proteins, including DNA poly
118 xP-flanked stop cassette, and the SV40 large T-antigen (iAST).
119                                              T-antigen immortalization of cells allowed cell growth.
120        Comparisons of polyoma and SV40 small T antigens implicate Abeta in the control of differentia
121  gland tumors induced by polyomavirus middle T antigen in JNK2(-/-) mice were more sensitive to CDDP
122 the results of their efforts to express SV40 T antigen in mature B cells of mice.
123 viral DNA, implicating CUL7 association with T antigen in MRN proteolysis.
124 re effective than full-length and 57kT large T antigen in promoting the growth of human and mouse fib
125 e novo by overprinting of the second exon of T antigen in the common ancestor of a large clade of mam
126 e used transgenic mice expressing SV40 large T antigen in their prostatic neuroendocrine cells, under
127 a viral oncogene that cooperates with middle T antigen in transformation.
128 inase expression induced expression of MCPyV T antigens in stratified squamous epithelial cells and M
129  the oncogenic activity of MCC tumor-derived T antigens in vivo, a conditional, tissue-specific mouse
130 growth factor alpha, but not simian virus 40 T-antigen, increase the rate of hepatocyte growth under
131 cell lines with the expression of SV40 large T antigen increased the levels of Ras activation and per
132  PP2A Abeta/Akt interaction by polyoma small T antigen increased turnover of Akt Ser-473 phosphorylat
133 sformation of many cell types in culture and T antigen induces neoplasia when expressed in rodents.
134 p68N-T antigen affinity, confirming that p68-T antigen interaction is vital for primosome function.
135                                    For small T antigens, interaction with PP2A is needed for each of
136                           Polyomavirus small t antigen is a viral oncogene that cooperates with middl
137 genic mice in which expression of SV40 large T antigen is driven by UPK II promoter.
138                          Although SV40 large T antigen is essential, it is not sufficient for cellula
139 f topo I with the C-terminal binding site on T antigen is required for these activities.
140                                              T antigen is required for viral DNA replication, transcr
141 l cell polyomavirus (MCPyV) expressing viral T antigens is a common feature of most Merkel cell carci
142                                              T-Antigen is found to be closely associated with cancer
143 ce that express a fragment of the SV40 small t antigen known to inhibit protein phosphatase 2A (PP2A)
144  large probasin promoter directed SV40-large T-antigen (LPB-Tag) expressing mouse prostate, mPIN form
145 protein phosphatase 2A (PP2A), and the large T antigen (LT) binds pRb, p107, p130, and p53.
146 monstrated that simian virus 40 (SV40) large T antigen (LT) binds to the Bub1 kinase, a key regulator
147 t the co-crystal structure of the SV40 Large-T Antigen (LT) hexameric helicase bound to its origin ds
148 pended on the coexpression of the SV40 large T antigen (LT) in the cells.
149                 Simian virus 40 (SV40) large T antigen (LT) is a multifunctional protein that is impo
150                 Simian virus 40 (SV40) large T antigen (LT), for example, targets p53 directly, but m
151 inding and helicase domains of the MCV large T antigen (LT), suggesting a selective pressure to remov
152 t expression of simian virus 40 (SV40) large T antigen (LT), without a viral origin, is sufficient to
153 iated DDR pathways accumulate in MCPyV large T antigen (LT)-positive nuclear foci in cells infected w
154  t-antigen (ST) collaborates with SV40 large T-antigen (LT) and activated rasv12 to promote transform
155 ens, pharmacologic interference of the large T antigen (LTA) may represent an effective therapeutic a
156            Phylogenetic trees based on large T-antigen (LTA) allow separation of subtype I into subgr
157 e prostate model that is driven, in part, by T antigen-mediated functional inactivation of p53.
158                      Here we found that SV40 T antigen-mediated transformation inhibits HCMV infectio
159 enesis in ovariectomized polyomavirus middle T-antigen mice.
160 rom Escherichia coli O127, which expresses a T-antigen mimic in the lipopolysaccharide (LPS) structur
161 use mammary tumor virus-polyoma virus middle T antigen (MMTV-PyMT)-induced breast cancer to conduct s
162 the mouse mammary tumor virus-polyoma middle T-antigen model.
163 the Mouse Mammary Tumor Virus-Polyoma Middle T-Antigen mouse.
164 ssing SV40 large T antigen and the levels of T antigen mRNA were reduced in infected human and monkey
165 locks tumor formation in both polyoma middle T antigen (MT) and HER2/Neu transgenic models of breast
166 re we characterize YAP as a target of middle T antigen (MT) important for transformation.
167                   The gene coding for middle T antigen (MT) is the murine polyomavirus oncogene most
168                                       Middle T antigen (MT) is the primary polyomavirus oncogene resp
169                                       Middle T antigen (MT) is the principal oncoprotein of murine po
170 reast cancer driven by either polyoma middle T antigen (MT) or HER2 is p110alpha dependent.
171 d differentiation and cooperates with middle T antigen (MT) to transform primary cells in vitro and i
172                                       Middle T antigen (MT), the oncogene of polyomavirus, can drive
173                                       Middle T antigen (MT), the principal oncoprotein of murine poly
174 ialyl Lewis-X (sLe(X)) and the di-sialylated T-antigen (NeuAcalpha2,3Galbeta1,3(NeuAcalpha2,6)GalNAc)
175 cal monopartite NLSs, such as c-myc and SV40 T-antigen NLSs.
176 at the addition of the simian virus 40 large-T-antigen nuclear localization signal (NLS) results in t
177 H was independently associated with JC virus T antigen (odds ratio [OR] = 1.93; P = .0077), body mass
178 ALTO is evolutionarily related to the middle T antigen of murine polyomavirus despite almost no seque
179 e and a cell line transformed with the large T antigen of simian virus 40, were developed, and both w
180 ic C subunit, in a manner similar to that of T antigens of the small DNA tumor viruses.
181        As in other polyomaviruses, the large T-antigen of MCV recognizes the viral origin of replicat
182 e studies uncover the action of polyomavirus T antigens on cellular CBP/p300 and suggest that additio
183            While the impact of MCV and viral T-antigens on MCC development has been extensively inves
184  in HER2/neu mice, but not in polyoma middle T-antigen oncomice.
185 PP2A) activity by either expression of small t antigen or depletion of PP2A/C by RNA interference enh
186 cells on activation of either polyoma middle T antigen or ErbB2 signaling.
187 d in cells immortalized by either SV40 large T antigen or p53-null mutation, whereas alpha3beta1-depe
188 vity because of the expression of SV40 large T-antigen or because of a mutation in the TP53 gene.
189 of PP2A with okadaic acid, fostriecin, small T antigen, or PP2A knockdown abrogated rapamycin-induced
190  two highly constrained regions of the large T antigen ORF provided a start codon and C-terminal hydr
191 the 2.9 A crystal structure of the MCV large T-antigen origin binding domain (OBD) in complex with a
192  1 and minimal intrarenal expression of SV40-T antigen (P < 0.001).
193 ntigen, suggesting a functional link between T antigen-p68 interaction and primosome activity.
194  of p68 residues in the interface diminished T antigen-p68 interaction, confirming the interaction si
195           Here, we report the detailed large T antigen-p68 interface, as revealed in a co-crystal str
196 ell lines show oncogene addiction to the MCV T antigens, pharmacologic interference of the large T an
197 case domains of simian virus 40 (SV40) large T antigen play a critical role in DNA replication.
198  motility of cells transformed by SV40 large T antigen plus activated ras.
199 ferences between SVST and polyomavirus small T antigen (POLST) in their effects on differentiation, t
200  prototypical NLS from simian virus 40 large T-antigen preferentially at the major NLS binding site.
201 sis on the cell-cell modules that complement T-antigen-presenting cell interaction, provides a fundam
202 ns with the unique T. cruzi trans-sialidase (TS) antigen protect against gastric and systemic T. cruz
203 isms were detected in the VP1, VP2 and Large T Antigen proteins, suggesting potential functional effe
204 that the binding of topo I to this region of T antigen provides the proper unwound DNA substrate for
205                Using the MMTV-Polyoma Middle T antigen (PyMT) mouse model of human ductal carcinoma,
206                      The polyomavirus middle T antigen (PyMT) oncogene activates the cellular nonrece
207 mary tumor virus (MMTV)-Polyoma virus middle T antigen (PyMT) or MMTV-c-Neu transgenic mice.
208 mmary tumorigenesis using the polyoma middle T antigen (PyMT) transgenic mouse model.
209 metastatic breast cancer, the polyoma middle T antigen (PyMT) transgenic mouse.
210                        In the polyoma middle T-antigen (PyMT) transgenic mouse model of breast cancer
211                    Murine polyomavirus small t antigen (PyST) regulates cell cycle, cell survival, ap
212                                Polyoma small T antigen (PyST), an early gene product of the polyoma v
213                        Like all polyomavirus T antigens, PyST functions largely via its interactions
214 c mice that express the polyoma virus middle T antigen (PyV-MT) in the mammary gland and that are wil
215                         Polyoma virus middle T antigen (PyVmT) is a powerful viral oncogene; however,
216 ncluding the widely used polyomavirus middle-T antigen (PyVmT) model, which provides an opportunity t
217 ctively, due to large deletions in the large T antigen region.
218 of miRNA-mediated negative regulation of the T antigens remains uncertain.
219 suppressor p53 and pRb in urothelium by SV40 T antigen resulted in urothelial carcinoma, resembling h
220 nslocation strand, suggesting that the large T antigen ring can open to bypass bulky adducts.
221 s from nontumor sources did not possess this T antigen signature mutation.
222              Fabpi-TAg mice expressing large T-antigen solely in villi had ectopic enterocyte prolife
223                              The MWPyV small T antigen (ST) binds protein phosphatase 2A (PP2A), and
224 ecently demonstrated that polyomavirus small T antigen (ST) binds YAP, a major effector of Hippo sign
225     We have previously shown that SV40 small t antigen (st) cooperates with deregulated cyclin E to a
226                                   SV40 small t antigen (ST) has been reported to be necessary and suf
227                   Coexpression of SV40 small t antigen (st), but not other tested oncogenes, efficien
228 e of the functions of the polyomavirus small T antigens (ST) are shared by the E6 and E7 oncoproteins
229                                   SV40 small t-antigen (ST) collaborates with SV40 large T-antigen (L
230 ress putative polyomavirus oncoprotein small T antigen (sTAg) and truncated large T antigen.
231 nds directly to the hexameric viral helicase T antigen, suggesting a functional link between T antige
232 es immortalized using simian virus 40 (SV40) T antigen, suggesting the possibility of transcomplement
233 hereas immortalization induced by SV40 large T antigen supported fibroblast proliferation in the abse
234                                   SV40 small T antigen (SVST) has received considerable attention bec
235                 Simian virus 40 (SV40) large T antigen (SVT) interferes with normal cell regulation a
236  promoter to target expression of SV40 large T-antigen (T-Ag) in the undifferentiated murine embryoni
237 domain (OBD) of simian virus 40 (SV40) large T-antigen (T-Ag) is essential for many of T-Ag's interac
238 rototypical replicative helicase, SV40 large T-antigen (T-ag), was investigated.
239 nity binding element for the viral initiator T-antigen (T-ag).
240 o address this question, we knocked down MCV T-antigen (TA) expression in MCV-positive MCC cell lines
241 r suppressor p53 (fused to Gal4BD) and large T antigen (TAg) (fused to VP16) was visualized in vivo b
242  the input virus nor the expression of large T antigen (TAg) alone is sufficient to trigger the activ
243 lleles, including the simian virus 40 (SV40) T antigen (TAg) and oncogenic H-Ras, inhibit HCMV infect
244                        Simian virus 40 large T antigen (TAg) contributes to cell transformation, in p
245  and emphasized the importance of functional T antigen (Tag) for efficient replication.
246  wild-type (WT) simian virus 40 (SV40) large T antigen (TAg) inhibits apoptosis via the activation of
247                        Simian virus 40 large T antigen (TAg) transforms cells in culture and induces
248 seeding of tumorigenic hepatocytes from SV40 T antigen (Tag) transgenic MTD2 mice into the livers of
249  origin and flanking sequences, to which BKV T antigen (Tag), cellular proteins, and small regulatory
250 duced activation of the oncogenic SV40 large T antigen (TAg).
251      In agreement, expression of large tumor T antigens (TAg) encoded by polyomaviruses in mammalian
252               The rat insulin promoter (RIP)-T-antigen (Tag) is a well characterized transgenic mouse
253 feron gamma (IFNgamma) induction of the SV40 T-antigen (TAg) was assayed by immunohistochemistry and
254                                 In addition, T antigen targets multiple cellular pathways, including
255 ns result in expression of a truncated large T antigen that retains the Rb binding or LXCXE motif but
256                                       Mutant T antigens that fail to bind topo I normally do not part
257 ng discovered provides a collection of novel T antigens that, like simian virus 40, can be used to di
258 sis of the common core 1 O-glycan structure (T-antigen), the precursor structure for most mucin-type
259 ormation assay that also includes SV40 large T antigen, the catalytic subunit of cellular telomerase,
260                           By contrast, large T antigen, the replicative DNA helicase of the simian vi
261 K may have potential applications in masking T-antigen, the tumor antigen, in vivo.
262 lization via genetic influences such as SV40 T-antigen, thus limiting our knowledge of the events tha
263 evels of SnoN cooperated with polyoma middle T antigen to accelerate the formation of aggressive mult
264 uses encoding the mouse polyoma virus middle T antigen to elastase-tv-a transgenic mice with a pancre
265 te (TRAMP) model of PCa that uses SV40 large T antigen to induce PCa, loss of Foxm1 decreased tumor g
266 ggest that additional mechanisms are used by T antigens to induce cell immortalization and transforma
267 defined oncogenic driver antigen (SV40 large T-antigen) to follow the activation and differentiation
268  BPCV1 miRNA is not encoded antisense to the T antigen transcripts but rather lies in a separate, pro
269 preserving the reading frame of the opposing T antigen transcripts.
270 , but were the cell line 661W, a mouse SV-40 T antigen transformed photoreceptor cell line.
271  selectively induces apoptosis of SV40 large T-antigen transformed cells and significantly reduces co
272 contrast to the half-life of simian virus 40 T antigen-transformed cells.
273                                 In contrast, T-antigen-transformed REF52 and p53+/+ HCT116 tumor cell
274 hrelinomas induced by a tissue-specific SV40 T-antigen transgene.
275              MATERIALS AND C3(1) Sv-40 large T antigen transgenic mice (n = 23) were studied with ins
276 eighted (DW)-MRI in the polyoma virus middle T antigen transgenic mouse model of breast cancer.
277 by using mammary tumour virus-polyoma middle T-antigen transgenic (PyMT) mice as a model of inherited
278 ination is a secondary occurrence, following T antigen-triggered oligodendroglial apoptosis.
279               Mice expressing Polyoma middle T antigen under the mouse mammary tumor virus promoter w
280 mouse prostate (TRAMP) mice express the SV40 T-antigen under the control of the probasin promoter, an
281                             Stimulation with TD antigens under inflammatory conditions induces plasma
282 e, and Tregs are produced in the presence of TD antigens under tolerance conditions.
283 genic expression of the polyoma virus middle T antigen, under control of the mouse mammary tumor viru
284                          Unexpectedly, large T antigen unwinds DNA past a DNA-protein crosslink on th
285 died these mutants to gain insights into how T antigen unwinds the origin.
286 these controversies, we detected MCPyV large T antigen using immunohistochemistry with two distinct a
287              The occurrence of T- and sialyl T-antigen varied in bovine and ovine reproductive tract
288 on induced by Merkel cell polyomavirus small T antigen viral oncoprotein.
289                In support of this, wild-type T antigen was able to specifically unwind a 31-bp DNA co
290                                  While large T antigen was expressed to higher levels in adar1(-/-) c
291           Furthermore, MCPyV-truncated large T antigen was more effective than full-length and 57kT l
292 ombination, transforming growth factor alpha/T-antigen, was sufficient to direct cell autonomous grow
293                However, JCV proteins (VP1 or T antigen) were detected mainly in the brains of 23/24 H
294 al oncoprotein, simian virus 40 (SV40) large T-antigen, which is frequently used to immortalize cells
295 his work shows how this association of small t antigen with YAP is important for its effects on cell
296                           Analysis of mutant T antigens with disrupted binding to the ubiquitin ligas
297 MWPyV is a widespread human virus expressing T antigens with low transforming potential.
298 roteins, by replacing SV40 large T and small T antigens with sh-p53, mutant CDK4 (CDK4(R24C)), and sh
299  to plasma cells in response to T-dependent (TD) antigens within germinal centers (GCs).
300          In contrast, tolerance induction by TD antigens without costimulation triggers the developme

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top